TriSalus Life Sciences, Inc. (TLSI) Free cash flow 2022–2025
TriSalus Life Sciences, Inc. (TLSI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.9MFY2025 · since FY2022: -$33.0M → -$18.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.9M | +54.0% |
| FY2024 | -$41.2M | +19.5% |
| FY2023 | -$51.2M | -55.2% |
| FY2022 | -$33.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Net marginTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →